Fig. 1: LncRNA HOXA-AS2 is highly expressed in glioma and indicates poor prognosis of patients with glioma. | Cell Death & Disease

Fig. 1: LncRNA HOXA-AS2 is highly expressed in glioma and indicates poor prognosis of patients with glioma.

From: HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis

Fig. 1

A A heat map of the expression of the top 10 differential genes in the GSE15824 dataset. B The expression of lncRNA HOXA-AS2 in glioma and normal samples in TCGA database. C LncRNA HOXA-AS2 expression in tumor tissues from glioma patients (N = 40) and normal brain tissues (N = 10) determined by RT-qPCR. D Correlation analysis between the lncRNA HOXA-AS2 expression and overall survival rates of patients with glioma using the Kaplan–Meier method. E LncRNA HOXA-AS2 expression in glioma cell lines U373-MAGI, LN229, A172, and T98G, and Heb cells determined by RT-qPCR. *p < 0.05. Data were shown as the mean ± standard deviation. Statistical comparisons were performed using unpaired t-test when only two groups were compared or by one-way ANOVA with Tukey’s post hoc test when more than two groups were compared. Cell experiments were repeated three times.

Back to article page